Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | S3I-201 |
| Synonyms | |
| Therapy Description |
S3I-201 (NSC 74859) is an inhibitor of Stat3 activity blocking Stat3 homodimer formation and Stat3 DNA binding (PMID: 17463090, PMID: 32565984). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| S3I-201 | NSC 74859 | STAT3 Inhibitor 26 | S3I-201 (NSC 74859) is an inhibitor of Stat3 activity blocking Stat3 homodimer formation and Stat3 DNA binding (PMID: 17463090, PMID: 32565984). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| BRAF V600E | melanoma | sensitive | S3I-201 | Preclinical | Actionable | In a preclinical study, S3I-201 inhibited cell invasion and Stat3 signaling in human melanoma cell lines harboring BRAF V600E that are resistant to Braf inhibition in culture (PMID: 23242808). | 23242808 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|